A sensitive fluorescent dye agent and preparation method thereof
By encapsulating the fluorescent dye in liposomes and using phospholipids and PEG cholesterol derivatives as carriers, the penetration and stability of the fluorescent dye in fluorescence analysis were solved, and better labeling performance and imaging effects were achieved.
Patent Information
- Application Number
- CN202310420235.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-04-19
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2043-04-19
AI Technical Summary
Existing organic small molecule fluorescent dyes have poor penetration, stability and compatibility in fluorescence analysis, which affects their labeling performance and imaging effects.
Using phospholipids, PEG cholesterol derivatives and phosphate buffer solutions as carriers, organic fluorescent dyes are encapsulated in liposomes, and a homogeneous membrane and dispersion are formed through high-speed shearing and ultrasonic treatment to prepare sensitive fluorescent dye agents to improve their Cell penetration and stability.
It enhances the cell membrane penetration and stability of fluorescent dyes, extends imaging time, improves labeling performance and imaging effects, and avoids the aggregation and toxicity of fluorescent dyes.
Smart Images

Figure CN116574394B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a sensitive fluorescent dye agent and a preparation method thereof, belonging to the technical field of fluorescent dyes. Background Art
[0002] Fluorescence analysis uses fluorescence signals to display microscopic information changes in a macroscopic form. Due to its advantages of high sensitivity, strong selectivity, and in-situ real-time response, it is widely used in identification and labeling. At the same time, it also promotes the development of fluorescent molecules towards higher brightness and higher stability. Existing organic small molecule fluorescent dyes used for fluorescence analysis, such as rhodamine, cyanine dyes, and fluorescein, carry charges themselves, which seriously affect the labeling performance, stability, and compatibility of the molecules. Rhodamine fluorescent dyes have poor lipophilicity and poor cell penetration; the negative ions of fluorescein molecules are easily oxidized to quenching and are not easy to penetrate the cell membrane; the polymethine chain of cyanine dyes is easily attacked by singlet oxygen, and the torsion of olefins leads to a decrease in quantum yield. In the era of vigorous development of super-resolution and fluorescent dye detection technology, most of the current research is on the group modification or structure of single-molecule organic small molecule fluorescent dyes, but there are still poor penetration, stability, and compatibility of fluorescent dyes, which have certain limitations in some occasions. Summary of the invention
[0003] In view of the problems existing in the above-mentioned prior art, the present invention provides a sensitive fluorescent dye agent and a preparation method thereof. The fluorescent dye agent has good cell penetrability, compatibility and stability, and its preparation is simple and convenient.
[0004] In order to achieve the above-mentioned purpose, the present invention adopts the following technical scheme: a sensitive fluorescent dye agent, which is composed of the following raw materials: phospholipids, PEG cholesterol derivatives, phosphate buffer solution, and organic fluorescent dyes, and the organic fluorescent dyes are encapsulated in the phospholipids; wherein the mass of the organic fluorescent dye is 41.3-46.5% of the mass of the phospholipids, the mass of the PEG cholesterol derivative is 23.8-27.3% of the mass of the phospholipids, and the mass of the phosphate buffer solution is 1.6-2 times the mass of the phospholipids.
[0005] Preferably, the phospholipid is a mixture of two or more of phosphatidylcholine, phosphatidylethanolamine or phosphatidylserine.
[0006] Preferably, the phospholipid is a mixture of phosphatidylcholine, phosphatidylethanolamine and phosphatidylserine in a weight ratio of 1:0.3:0.45.
[0007] The phospholipids are prepared by mixing phosphatidylcholine and phosphatidylethanolamine in a weight ratio of 1:0.0.68.
[0008] The phospholipids are mixed with phosphatidylcholine and phosphatidylserine in a weight ratio of 1:0.82.
[0009] Preferably, the PEG cholesterol derivative is one of cholesterol-polyethylene glycol-amino, cholesterol-polyethylene glycol-carboxyl or cholesterol-polyethylene glycol-hydroxyl.
[0010] Preferably, the organic fluorescent dye is one of rhodamine 6G, rhodamine 123, rhodamine B, fluorescein, cyanine dye Cy3, cyanine dye Cy3.5, cyanine dye Cy5, cyanine dye Cy5.5, cyanine dye Cy7, cyanine dye Cy7.5, cyanine dye sulfo-Cy3, cyanine dye sulfo-Cy5, cyanine dye sulfo-Cy7, etc.
[0011] Preferably, the pH of the phosphate buffer solution is 6 to 6.5.
[0012] The present invention also provides a method for preparing a sensitive fluorescent dye, comprising the following steps:
[0013] (1) adding phospholipids to pure water containing ethanol, and subjecting to high-speed shearing for 30 to 35 minutes, firstly subjecting to a first ultrasonic treatment at 25 to 30° C., and then subjecting to a first reduced-pressure rotary evaporation at 40 to 45° C., to form a homogeneous film;
[0014] (2) dissolving the PEG cholesterol derivative in a phosphate buffer solution and subjecting it to high-speed shearing for 30 to 35 minutes at normal pressure to form a dispersion;
[0015] (3) adding the dispersion liquid to the homogeneous film, dispersing and emulsifying it by high-speed shearing, then adding the organic fluorescent dye, continuing the high-speed shearing and heating to 30-35° C. for hydration for 45-50 minutes, then performing a second ultrasonic treatment at 25-30° C., and sterilizing it by a microporous filter membrane to obtain a sensitive fluorescent dye agent.
[0016] Preferably, the first and second ultrasonic treatments are intermittent ultrasonic treatments with a power of 60-65W.
[0017] The ultrasound was performed every 2 seconds, each ultrasound lasted for 3 seconds, and the total ultrasound time was 21 to 24 seconds.
[0018] Preferably, the mass fraction of ethanol in the pure water containing ethanol is 60-70%.
[0019] Preferably, the mass of pure water containing ethanol is 3 to 5 times that of phospholipids.
[0020] The beneficial effects of the present invention are as follows: the sensitive fluorescent dye agent of the present invention encapsulates the fluorescent dye in liposomes, and uses PEG cholesterol derivatives for emulsification and dispersion, so that the fluorescent dye has both hydrophilic solubility and hydrophobicity, thereby enhancing the sensitivity of the fluorescent dye to the cell body and improving the penetration of the fluorescent dye to the cell membrane; at the same time, the liposome encapsulates the fluorescent dye, reduces the release of the fluorescent dye during the imaging transmission process, and improves the stability of the fluorescent dye during the imaging transmission process; the liposome molecular particle size in the sensitive fluorescent dye agent of the present invention has good dispersibility, can also avoid the agglomeration of the fluorescent dye, prolong the imaging time, and has good imaging effect; the sensitive fluorescent dye agent of the present invention can effectively realize the transmission of the fluorescent dye in the body, improve the labeling performance of the fluorescent dye molecules, and improve the in vivo imaging effect; the sensitive fluorescent dye agent of the present invention does not require the assistance of organic solvents when used, and can reduce toxicity. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 The fluorescence intensity of the liposomes in the intact state in the sensitive fluorescent dye agent of Examples 1 to 6 and Comparative Example 5;
[0022] Figure 2 It is the fluorescence intensity after the liposomes of Examples 1 to 6 and Comparative Example 5 are ruptured. DETAILED DESCRIPTION
[0023] In order to explain the present invention more clearly and completely, the present invention is described below with specific embodiments, but the present invention is not limited thereto.
[0024] Example 1
[0025] A sensitive fluorescent dye agent, the specific preparation method steps are as follows:
[0026] (1) 10 g of phospholipids prepared by mixing phosphatidylcholine and phosphatidylethanolamine in a weight ratio of 1:0.0.68 was added to 30 g of pure water with an ethanol mass fraction of 70%, and after high-speed shearing for 30 to 35 min, the first ultrasonic treatment was performed at 25 to 30° C., and then the ultrasonic treatment was performed once every 2 seconds at a power of 60 to 65 W, and the ultrasonic treatment lasted for 3 seconds each time, with a total ultrasonic treatment time of 21 seconds. Then, the first vacuum rotary evaporation was performed at 40 to 45° C. to form a homogeneous film;
[0027] (2) dissolving 2.38 g of cholesterol-polyethylene glycol-amino in 16 g of a phosphate buffer solution having a pH of 6 to 6.5, and subjecting the solution to high-speed shearing for 30 to 35 min at normal pressure to form a dispersion;
[0028] (3) Add the dispersion to the homogeneous film, disperse and emulsify it by high-speed shearing, then add 4.13 g of rhodamine B, continue high-speed shearing and heat to 30-35° C. for hydration for 45-50 min, then perform a second ultrasonic treatment at 25-30° C., at a power of 60-65 W, sonicate once every 2 seconds, each ultrasonication for 3 seconds, and a total ultrasonication time of 21 seconds, and sterilize through a microporous filter membrane to obtain a sensitive fluorescent dye agent.
[0029] Example 2
[0030] A sensitive fluorescent dye agent, the specific preparation method of which is as follows: (1) adding 10g of phospholipids prepared by mixing phosphatidylcholine and phosphatidylserine in a weight ratio of 1:0.82 to 40g of pure water with an ethanol mass fraction of 65%, and subjecting the mixture to high-speed shearing for 30 to 35 minutes, firstly subjecting the mixture to a first ultrasonic treatment at 25 to 30°C, and then subjecting the mixture to an ultrasonic treatment at a power of 60 to 65W, subjecting the mixture to an ultrasonic treatment every 2 seconds for 3 seconds each time, and subjecting the mixture to an ultrasonic treatment for a total of 24 seconds, and then subjecting the mixture to a first vacuum rotary evaporation at 40 to 45°C to form a homogeneous film;
[0031] (2) dissolving 2.38 g of cholesterol-polyethylene glycol-amino in 16 g of a phosphate buffer solution having a pH of 6 to 6.5, and subjecting the solution to high-speed shearing for 30 to 35 min at normal pressure to form a dispersion;
[0032] (3) Add the dispersion to the homogeneous film, disperse and emulsify it under high-speed shearing, then add 4.13 g of rhodamine B, continue high-speed shearing and heat to 30-35° C. for hydration for 45-50 min, then perform a second ultrasonic treatment at 25-30° C., at a power of 60-65 W, sonicate once every 2 seconds, each ultrasonication for 3 seconds, and a total ultrasonication time of 24 seconds, and sterilize through a microporous filter membrane to obtain a sensitive fluorescent dye agent.
[0033] Example 3
[0034] A sensitive fluorescent dye agent, the specific preparation method steps are as follows:
[0035] (1) adding 10 g of phospholipids prepared by mixing phosphatidylcholine, phosphatidylethanolamine and phosphatidylserine in a weight ratio of 1:0.25:0.45 to 30 g of pure water with an ethanol mass fraction of 65%, and subjecting the mixture to high-speed shearing for 30 to 35 min, first subjecting the mixture to a first ultrasonic treatment at 25 to 30° C., subjecting the mixture to an ultrasonic treatment at a power of 60 to 65 W, subjecting the mixture to an ultrasonic treatment every 2 s for 3 s each time, and subjecting the mixture to an ultrasonic treatment for a total of 21 s, and then subjecting the mixture to a first vacuum rotary evaporation at 40 to 45° C. to form a homogeneous film;
[0036] (2) dissolving 2.38 g of cholesterol-polyethylene glycol-amino in 16 g of a phosphate buffer solution having a pH of 6 to 6.5, and subjecting the solution to high-speed shearing for 30 to 35 min at normal pressure to form a dispersion;
[0037] (3) Add the dispersion to the homogeneous film, disperse and emulsify it by high-speed shearing, then add 4.13 g of rhodamine B, continue high-speed shearing and heat to 30-35° C. for hydration for 45-50 min, then perform a second ultrasonic treatment at 25-30° C., at a power of 60-65 W, sonicate once every 2 seconds, each ultrasonication for 3 seconds, and a total ultrasonication time of 21 seconds, and sterilize through a microporous filter membrane to obtain a sensitive fluorescent dye agent.
[0038] Example 4
[0039] The sensitive fluorescent dye agent of this embodiment 4 is the same as that of embodiment 3, except that the phospholipid of this embodiment 4 is a mixture of phosphatidylcholine, phosphatidylethanolamine and phosphatidylserine in a weight ratio of 1:0.3:0.45.
[0040] Example 5
[0041] The sensitive fluorescent dye agent of this embodiment 5 is the same as that of embodiment 1, except that the PEG cholesterol derivative of this embodiment 6 is cholesterol-polyethylene glycol-carboxyl.
[0042] Example 6
[0043] The sensitive fluorescent dye agent of this embodiment 6 is the same as that of embodiment 1, except that the PEG cholesterol derivative of this embodiment 6 is cholesterol-polyethylene glycol-hydroxyl.
[0044] Example 7
[0045] A sensitive fluorescent dye agent, the specific preparation method steps are as follows:
[0046] (1) 10 g of phospholipids prepared by mixing phosphatidylcholine and phosphatidylethanolamine in a weight ratio of 1:0.0.68 was added to 50 g of pure water with an ethanol mass fraction of 60%, and after high-speed shearing for 30 to 35 min, the first ultrasonic treatment was performed at 25 to 30° C., and then the ultrasonic treatment was performed once every 2 seconds at a power of 60 to 65 W, and the ultrasonic treatment lasted for 3 seconds each time, with a total ultrasonic treatment time of 24 seconds. Then, the first vacuum rotary evaporation was performed at 40 to 45° C. to form a homogeneous film;
[0047] (2) dissolving 2.58 g of cholesterol-polyethylene glycol-carboxyl in 20 g of phosphate buffer solution at a pH of 6 to 6.5, and subjecting the solution to high-speed shearing for 30 to 35 min at normal pressure to form a dispersion;
[0048] (3) Add the dispersion to the homogeneous film, disperse and emulsify it by high-speed shearing, then add 4.35 g of rhodamine 6G, continue high-speed shearing and heat to 30-35° C. for hydration for 45-50 min, then perform a second ultrasonic treatment at 25-30° C., at a power of 60-65 W, sonicate once every 2 seconds, each ultrasonication for 3 seconds, and a total ultrasonication time of 24 seconds, and sterilize through a microporous filter membrane to obtain a sensitive fluorescent dye agent.
[0049] Example 8
[0050] A sensitive fluorescent dye agent, the specific preparation method of which is as follows: (1) adding 10g of phospholipids prepared by mixing phosphatidylcholine and phosphatidylserine in a weight ratio of 1:0.82 to 30g of pure water with an ethanol mass fraction of 65%, and subjecting the mixture to high-speed shearing for 30 to 35 minutes, firstly subjecting the mixture to a first ultrasonic treatment at 25 to 30°C, and subjecting the mixture to an ultrasonic treatment at a power of 60 to 65W, subjecting the mixture to an ultrasonic treatment once every 2 seconds, subjecting the mixture to an ultrasonic treatment once for 3 seconds, and subjecting the mixture to an ultrasonic treatment for a total of 21 seconds, and then subjecting the mixture to a first vacuum rotary evaporation at 40 to 45°C to form a homogeneous film;
[0051] (2) dissolving 2.73 g of cholesterol-polyethylene glycol-hydroxy in 18 g of a phosphate buffer solution having a pH of 6 to 6.5, and subjecting the solution to high-speed shearing for 30 to 35 min at normal pressure to form a dispersion;
[0052] (3) Add the dispersion liquid to the homogeneous film, disperse and emulsify it by high-speed shearing, then add 4.65 g of cyanine dye Cy7, continue high-speed shearing and heat to 30-35°C for hydration for 45-50 min, then perform a second ultrasonic treatment at 25-30°C, at a power of 60-65 W, sonicate once every 2 seconds, each ultrasonication for 3 seconds, and a total ultrasonication time of 21 seconds, and sterilize through a microporous filter membrane to obtain a sensitive fluorescent dye agent.
[0053] Comparative Example 1
[0054] The sensitive fluorescent dye agent of this comparative example 1 is the same as that of Example 1, except that the phospholipid of this comparative example 1 is phosphatidylcholine.
[0055] Comparative Example 2
[0056] The sensitive fluorescent dye agent of this comparative example 2 is the same as that of Example 1, except that the phospholipid of this comparative example 2 is phosphatidylethanolamine.
[0057] Comparative Example 3
[0058] The sensitive fluorescent dye agent of this comparative example 3 is the same as that of Example 1, except that the phospholipid of this comparative example 3 is phosphatidylserine.
[0059] Comparative Example 4
[0060] The sensitive fluorescent dye agent of this comparative example 4 is the same as that of Example 1, except that: in step (2) of this comparative example 4, 2.38 g of cholesterol is dissolved in 16 g of phosphate buffer solution with a pH of 6 to 6.5.
[0061] Comparative Example 5
[0062] The sensitive fluorescent dye agent of this comparative example 5 is the same as that of Example 1, except that: the first and second ultrasonic treatments of this comparative example 5 are continuous ultrasonic treatments, and the ultrasonic time is 21.
[0063] Comparative Example 6
[0064] The sensitive fluorescent dye agent of this comparative example 6 is the same as that of Example 1, except that: the first and second ultrasonic treatments of this comparative example 6 are intermittent ultrasonic treatments, with ultrasonic treatment once every 2 seconds, each ultrasonic treatment lasting 2 seconds, and a total ultrasonic treatment time of 24 seconds.
[0065] Effect Example
[0066] 1. Take the sensitive fluorescent dyes prepared in Examples 1 to 6 and Comparative Examples 1 to 6, concentrate by rotary evaporation at 30-35°C, dry, and test. The results are shown in Table 1.
[0067]
[0068] According to Table 1 above, the sensitive fluorescent dye agent of the present invention, compared with comparative examples 1 to 3, after concentration and drying, Examples 1 to 8 have higher encapsulation rates, which are greater than 91%, uniform particle size distribution, and better dispersibility; compared with comparative examples 5 and 6, Examples 1 to 8 have higher encapsulation rates, which are greater than 91%, smaller particle sizes, which are around 110, and the particle sizes are basically unchanged after being placed for a period of time, and the dispersibility is also better; therefore, the sensitive fluorescent dye agent of the present invention has good stability.
[0069] 2. Take the sensitive fluorescent dyes encapsulating rhodamine B prepared in Examples 1 to 6 above, and measure the fluorescence intensity of the liposomes in the intact state and the fluorescence intensity of the liposomes after rupture. The results are as follows: Figure 1 The fluorescence intensity of the liposomes in the intact state is shown in Figure 2. Figure 2 Fluorescence intensity after liposome rupture is shown;
[0070] from Figure 1 and Figure 2It was found that the fluorescence in the intact state of the liposome is quenched, and the fluorescence can be restored after the liposome is ruptured. Moreover, the higher the encapsulation rate of the liposome, the higher the intensity of the fluorescent dye in the later stage of liposome rupture, indicating that the liposome encapsulation of the fluorescent dye can effectively avoid the fluorescent dye from being quenched during the transportation process. Combined with Table 1, it is shown that the high encapsulation rate of the liposome helps to reduce the release of the fluorescent dye during the imaging transmission process, can improve the stability of the fluorescent dye during the imaging transmission process, and helps to extend the imaging time and improve the imaging effect; compared with Example 1 and Example 2, Example 4 and Example 3 have better encapsulation rates of fluorescent dyes with phospholipids mixed with phosphatidylcholine, phosphatidylethanolamine and phosphatidylserine; compared with Comparative Example 5, Example 1, Example 2, Example 5 and Example 6 use PEG cholesterol derivatives such as cholesterol-polyethylene glycol-amino, cholesterol-polyethylene glycol-carboxyl or cholesterol-polyethylene glycol-hydroxyl to disperse and emulsify the phospholipids. After the liposome is ruptured, the PEG cholesterol derivatives increase the sensitivity of the fluorescent dye and increase the fluorescence intensity.
[0071] In addition to liposome encapsulation of rhodamine B, Example 7 also provides encapsulation of rhodamine 6G, and Example 8 also provides encapsulation of cyanine dye Cy7. In addition, a large number of experiments have been conducted on different fluorescent organic fluorescent dyes such as rhodamine 123, fluorescein, cyanine dye Cy3, cyanine dye Cy3.5, cyanine dye Cy5, cyanine dye Cy5.5, cyanine dye Cy7.5, cyanine dye sulfo-Cy3, cyanine dye sulfo-Cy5, and cyanine dye sulfo-Cy7. The results of the fluorescence intensity of the fluorescent dyes in the intact liposome state and the fluorescence intensity of the fluorescent dyes in the ruptured liposome state are similar to those of the liposomes. Figure 1 , Figure 2 Therefore, the fluorescence of the sensitive fluorescent dye agent of the present invention is quenched in the intact state of liposomes. After the liposomes are ruptured, the fluorescence can be restored, and the higher the encapsulation rate of the liposomes, the higher the intensity of the fluorescent dye in the later stage of liposome rupture, indicating that liposome encapsulation of fluorescent dyes can effectively avoid quenching of fluorescent dyes during transportation, reduce the release of fluorescent dyes during imaging transmission, and improve the stability of fluorescent dyes during imaging transmission, which helps to prolong imaging time and improve imaging effects. The liposomes of the sensitive fluorescent dye agent of the present invention enable the fluorescent dye agent to have good cell penetrability, compatibility and stability.
[0072] Finally, it should be noted that the above embodiments are only used to illustrate rather than limit the technical solutions of the present invention. Although the present invention has been described in detail with reference to the above embodiments, those skilled in the art should understand that the present invention can still be modified or replaced by equivalents. Any modification or partial replacement that does not depart from the spirit and scope of the present invention should be included in the scope of the claims of the present invention.
Claims
1. A sensitive fluorescent dye agent, characterized in that: The invention is composed of the following raw materials: phospholipid, PEG cholesterol derivative, phosphate buffer solution, and organic fluorescent dye, wherein the organic fluorescent dye is encapsulated in the phospholipid; wherein the mass of the organic fluorescent dye is 41.3-46.5% of the mass of the phospholipid, the mass of the PEG cholesterol derivative is 23.8-27.3% of the mass of the phospholipid, and the mass of the phosphate buffer solution is 1.6-2 times of the mass of the phospholipid; Phospholipids are a mixture of two or more of phosphatidylcholine, phosphatidylethanolamine or phosphatidylserine; The preparation method of the sensitive fluorescent dye agent is as follows: (1) adding phospholipids to pure water containing ethanol, high-speed shearing for 30 to 35 minutes, firstly performing a first ultrasonic treatment at 25 to 30° C., and then performing a first vacuum rotary evaporation at 40 to 45° C. to form a homogeneous film; (2) dissolving the PEG cholesterol derivative in a phosphate buffer solution and subjecting it to high-speed shearing for 30 to 35 minutes at normal pressure to form a dispersion; (3) Adding the dispersion liquid to the homogeneous film, dispersing and emulsifying it by high-speed shearing, then adding the organic fluorescent dye, continuing the high-speed shearing and heating to 30-35°C for hydration for 45-50 minutes, then performing a second ultrasonic treatment at 25-30°C, sterilizing it by microporous filtration membrane, and obtaining a sensitive fluorescent dye agent; The first and second ultrasonic treatments are intermittent ultrasonic treatments, wherein the ultrasonic treatment is performed once every 2 seconds, each ultrasonic treatment lasts for 3 seconds, and the total ultrasonic treatment time is 21 to 24 seconds.
2. A sensitive fluorescent dye agent according to claim 1, characterized in that: The phospholipids are mixed with phosphatidylcholine, phosphatidylethanolamine and phosphatidylserine in a weight ratio of 1:0.3:0.
45.
3. A sensitive fluorescent dye agent according to claim 1, characterized in that: The PEG cholesterol derivative is one of cholesterol-polyethylene glycol-amino, cholesterol-polyethylene glycol-carboxyl or cholesterol-polyethylene glycol-hydroxyl.
4. A sensitive fluorescent dye agent according to claim 1, characterized in that: The organic fluorescent dye is one of rhodamine 6G, rhodamine 123, rhodamine B, fluorescein, cyanine dye Cy3, cyanine dye Cy3.5, cyanine dye Cy5, cyanine dye Cy5.5, cyanine dye Cy7, cyanine dye Cy7.5, cyanine dye sulfo-Cy3, cyanine dye sulfo-Cy5 or cyanine dye sulfo-Cy7.
5. A sensitive fluorescent dye agent according to claim 1, characterized in that: The pH of phosphate buffer solution is 6~6.
5.
6. A method for preparing the sensitive fluorescent dye agent according to claim 1, characterized in that: The following steps are involved: (1) Add phospholipids to pure water containing ethanol, and after high-speed shearing for 30-35 minutes, perform the first ultrasonic treatment at 25-30°C, and then perform the first vacuum rotary evaporation at 40-45°C to form a homogeneous film; (2) dissolving the PEG cholesterol derivative in a phosphate buffer solution and subjecting it to high-speed shearing for 30 to 35 minutes at normal pressure to form a dispersion; (3) Adding the dispersion liquid to the homogeneous film, dispersing and emulsifying it by high-speed shearing, then adding the organic fluorescent dye, continuing the high-speed shearing and heating to 30-35°C for hydration for 45-50 minutes, then performing a second ultrasonic treatment at 25-30°C, sterilizing it by microporous filtration membrane, and obtaining a sensitive fluorescent dye agent; The first and second ultrasonic treatments: The ultrasonic treatments were intermittent with a power of 60-65 W; the ultrasonic treatments were performed every 2 seconds, each time for 3 seconds, and the total ultrasonic treatment time was 21-24 seconds.
Citation Information
Patent Citations
Phospholipases, nucleic acids encoding them and methods for making and using them
CN101426918A
Method for preparing natural material-liposome composite nanofiber based on electrostatic spinning technology
CN102797074A
Near-infrared fluorescent nanoparticle in-vivo probe and preparation method thereof
CN102876328A
Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions
CN103037913A
Thermo-sensitive liposome as well as preparation method and application thereof
CN103908429A
